Le Lézard
Classified in: Health
Subject: TRI

Duke Study to Determine Optimal Patient Repositioning Intervals to Prevent Pressure Ulcers


PLEASANTON, Calif., Sept. 13, 2017 /PRNewswire/ -- Duke University School of Nursing researchers have launched a five-year study to determine optimal timing for turning or repositioning patients to reduce the risk of pressure ulcers, which affect up to 24 percent of long-term care residents, 10 percent of hospital patients, and add $11 billion to annual U.S. healthcare costs.  

Pressure ulcers are skin lesions that occur when pressure constricts blood flow to the skin over a bony region, eventually leading to tissue death. They typically develop when hospital patients and nursing home residents are immobile, and are associated with painful complications, prolonged hospital stays and even death.

Caregivers prevent pressure ulcers by repositioning patients frequently to minimize compression of a single point. Medical best practice calls for patients to move every two hours, a standard developed more than 150 years ago and supported by a small study from 1962.

The Duke study, funded by the National Institutes of Nursing Research, part of the National Institutes of Health, will determine whether nursing home resident repositioning can be extended to three or four hours without increasing the incidence rates. It will determine:

"We need this information to decide how to deliver the best prevention care realistically and safely," said Tracey L. Yap, RN, PhD, FAAN, associate professor at Duke University School of Nursing and the principal investigator. "The standard patient turn protocol of two hours was originally set by Florence Nightingale.  We are overdue to find updated ways to improve quality of life while reducing facility-acquired pressure ulcers and lowering healthcare costs."

The study will use innovative technology: the Leaf Patient Monitoring System, which electronically monitors patients' mobility and automatically documents their progress along a prescribed mobility protocol. The system tracks movement and activity in bed-bound, chair-bound, or ambulatory patients. Leaf's wearable, wireless sensor will continuously monitor residents' mobility and activity at nine nursing homes and automatically track patient repositioning.

Dr. Yap's research team includes Susan Kennerly, PhD RN, FAAN (East Carolina University); Susan Horn, PhD (University of Utah), Nancy Bergstrom, PhD, RN, FAAN, and Santanu Datta, PhD, and Cathleen Colon-Emeric, MD, FACP (both of Duke).

About Leaf Healthcare, Inc.

Leaf Healthcare creates wireless patient monitoring solutions for healthcare providers seeking efficient, cost effective ways to improve patient safety and clinical outcomes.  Its patient monitoring system wirelessly monitors patient position and movement and uses that data to automate and document mobility protocols for patients.  The company will incorporate more monitoring features and capabilities into its technology platform, enabling more improvements to patient safety, clinical efficiency and patient outcomes. To learn more, visit www.leafhealthcare.com.

Media Contact:

Mark Smith
Leaf Healthcare
844-826-5323 
[email protected]

Jim Martinez
312-543-9026 
[email protected]

SOURCE Leaf Healthcare


These press releases may also interest you

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...



News published on and distributed by: